Investor Presentaiton slide image

Investor Presentaiton

Forecast for FY2023 Full-year earnings forecast remains unchanged from initial forecast While healthcare business is expected to grow, there are concerns about sluggish demand due to factors such as slow economic recovery in China Full recovery of AC production facilities is on schedule as originally planned, Plan to implement initiatives looking ahead to production recovery in the second half Change (YoY) FY 2022 FY2023 Forecast To sales (Million of yen) (%) To sales (%) Percentage Amount (%) Net sales 104,208 105,000 792 0.8 Operating income 15,557 14.9 10,000 9.5 (5,557) (35.7) Ordinary income 17,164 16.5 11,100 10.6 (6,064) (35.3) Net income 10,570 10.1 7,500 7.1 (3,070) (29.1) Earning per share 428.43 yen - 294.81 yen Overseas sales 39,675 38.1 37,200 35.5 (2,475) (2.6) Average Assumptions exchange rate Yen / Euro FY2022 FY2023 Yen / USD 134 Yen 137 Yen 140 Yen 150 Yen Naphtha price (Yen / KL) Something Better with Chemicals 75,500 Yen 63,500 Yen OSAKA SODA 11
View entire presentation